Socially Determined identifies social risks and provides insights to prevent workplace social determinants of health (SDOH) with their software. Through Socialy Determined's software, theyr social risk intelligence platform informs the clients' organization's intervention strategies to identify the social risk drivers affecting the workplace. Socially Determined was established on January 22, 2017 by Trenor Williams, and Ryan Bosch in Washington, DC.
CancerIQ provides a precision prevention platform that empowers healthcare providers to engage patients, stratify risk and ensure adherence with the latest evidence-based strategies to get ahead of cancer. It offers a robust content library of evidence-based guidelines and risk models to help providers interpret data and navigate patients to the appropriate genetic testing, screening, or treatment interventions.
Epitel is a digital health company developing a wearable, wireless EEG monitoring platform to provide accessible, affordable, and reliable for seizure detection.
TailorMed is a health IT company that works with providers, pharmacies and manufacturers to reduce patient financial toxicity and create efficiencies across the patient treatment lifecycle. Our end-to-end platform applies algorithms and automations to make the co-pay assistance and free drug order processes seamless and leverages our deep data set to create actionable insights.
DotCom Therapy specializes in providing speech therapy, occupational therapy, and mental health services via computer, tablet, or smartphone. They hand-match students, patients, and clients with our therapists who provide the highest quality therapy in a live, online, face-to-face setting. It offers speech, occupational and mental health therapy, educational audiology, case management, and literacy services. The company was founded in 2015 and is based in Madison, Wisconsin, United States.
Exela Pharma Sciences, LLC is a fast-growing US-based integrated specialty pharmaceutical company, that develops, manufactures, and markets proprietary and generic sterile injectable products with the healthcare provider and patient in mind. We are passionate about alleviating or eliminating drug shortages. Exela receives awards for its supply chain commitment and dedication to creating hundreds of high-value jobs in rural America.
Current Health help healthcare reduces risk & cost by monitoring, managing, and engaging patients at home.
Renovia was a developer of prescription digital therapeutics for pelvic floor disorders. Renovia ceased operations in late 2022 after its investors conducted a strategic review including considering a sale of the company. In January 2023, substantially all the assets of the company, including its intellectual property, were sold to Axena Health, Inc.
Recuro Health delivers value throughout the healthcare ecosystem with an integrated digital health solution that transitions the U.S. healthcare system from a reactive, disease-focused model to a population health, outcomes approach. Digital Medical Home can be tailored to specific healthcare requirements. They offer fundamental virtual care services such as primary care, behavioral health, and urgent care.
Inflammatix develops novel molecular diagnostics for acute infections and sepsis that work by 'reading' the immune system. It is a molecular diagnostics company developing rapid tests that read the immune system to resolve major clinical and public health challenges. They are initially focused on developing tests for acute bacterial and viral infections, and sepsis based on patent-pending biomarkers exclusively licensed from Stanford University.
DotCom Therapy specializes in providing speech therapy, occupational therapy, and mental health services via computer, tablet, or smartphone. They hand-match students, patients, and clients with our therapists who provide the highest quality therapy in a live, online, face-to-face setting. It offers speech, occupational and mental health therapy, educational audiology, case management, and literacy services. The company was founded in 2015 and is based in Madison, Wisconsin, United States.
PhotoniCare is a medical device company developing a patented imaging platform technology that provides growth opportunities beyond otology. Its ear diagnosis devices utilize advanced light-based technology to see through the eardrum to directly and harmlessly visualize the middle ear, determine quickly and easily the contents of the middle ear, and decide which antibiotics or surgical interventions might be needed.
VIDA modernizes lung and respiratory care, empowering healthcare organizations and physicians to improve patient outcomes, streamline care coordination and drive efficiencies through a comprehensive approach, proven quality, and clinical leadership. Through quantitative data intelligence and impactful visualizations, VIDA helps physicians manage patients with or at risk of chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD), lung cancer, and now, COVID-19. VIDA’s software is FDA cleared, CE-marked, Health Canada licensed and TGA registered for clinical use in the US, European Economic Area, Canada, and Australia. Learn more at vidalung.ai.
SilverCloud Health provides immediate access to evidence-based and supported digital therapies. SilverCloud’s engagement has shown a three-fold increase in client/patient engagement and a three-fold decrease in client/patient program dropout when compared with current leading online therapeutic products. It was founded in 2011 and headquartered in Boston, Massachusetts.
CareSignal provides an accessible remote patient monitoring platform that improves payer and provider performance in value-based care by engaging and identifying rising-risk patients. Care teams receive real-time alerts enabling real-time prioritization and outreach, and patients respond to evidence-based questions via text messages or phone calls.
Health Scholars is a developer of medical simulation training software intended to provide clinical education and training. The company's platform is easy to use and scalable across a health system and effectively manages, delivers and includes interactive training content including the only commercially available as well as clinical VR simulation, enabling users to get cost-effective and richer content experience.
Pieces is a healthcare artificial intelligence and technology company that connects health systems and the community to address clinical and social determinants of health through community networks and intelligent software and services. Our solution interprets patient information in real-time and connects health systems and community-based organizations to support healthier outcomes, both inside and outside of hospital walls. Using cloud-based artificial intelligence with clinically-based natural language processing (NLP) and physician-supervised machine learning, our tools help streamline clinician workflows and improve patient outcomes. Combined, our solutions, Pieces Predict and Pieces Connect, create a comprehensive and unique solution for connected community health.
Socially Determined identifies social risks and provides insights to prevent workplace social determinants of health (SDOH) with their software. Through Socialy Determined's software, theyr social risk intelligence platform informs the clients' organization's intervention strategies to identify the social risk drivers affecting the workplace. Socially Determined was established on January 22, 2017 by Trenor Williams, and Ryan Bosch in Washington, DC.
410 Medical has developed a simple, intuitive solution that allows a single healthcare provider to rapidly deliver fluid to critically ill patients, improving care, and saving lives. Their device allows fast set-up, improves resuscitation speed, minimizes provider fatigue, and frees providers to address other patient care issues simultaneously. This solution is particularly useful in pre-hospital settings and the emergency department and where speed is critical and resources may be limited. It was founded in 2013 and headquartered in Durham, North Carolina.
InsightRX is a software platform that incorporates the principles of quantitative pharmacology and machine learning to provide an individualized understanding of a patient’s response to treatment. It delivers its technology in the form of easy-to-use clinical decision support tools at the point-of-care to help guide treatment decision-making. The platform guides treatment decisions at both the individual level and the population level. InsightRX controls clinically validated pharmacokinetic models, patient physiology, pharmacogenomics, drug concentrations, and biomarkers to optimize dosing. It combines real-time patient data and machine learning to understand individual patient pharmacology and inform dose optimization. The platform also leverages disease-based pharmacodynamics models to inform treatment decision making. InsightRX was launched in 2015 by Ron Keizer, Sirj Goswami, and Ranvir Mangat. It is operated from San Francisco, California.
Exo is a medical device startup handheld ultrasound platform and AI for imaging and therapeutic applications. The company is committed to delivering affordable and easy-to-use medical imaging to healthcare professionals around the world. By delivering easy-to-use, high-quality medical imaging. Exo empowers healthcare professionals to make critical, real-time decisions that improve patient outcomes. The Exo ultrasound platform combines advances in nano-materials, novel sensor technologies, advanced signal processing, and computation with the economies of scale of semiconductor manufacturing to dramatically reduce the cost of imaging. It also represents a giant leap in imaging and therapeutics technology one that will drive the development of high-performance products that are accessible, easy-to-use, and available at a price point never before possible.
Paradigm brings cutting-edge diagnostics and biomarker driven clinical trials to benefit cancer patients.Through Next-Gen Sequencing, and other biomarker analysis, Paradigm is able to provide information about the genomic and proteomic landscape of a patient’s cancer, as well as potential therapies based on the specific characterization of the patient’s tumor; thus, personalizing each patient’s course of treatment.
Gauss Surgical is a med-tech company that develops a vision-based platform for accurate and real-time measurement of surgical blood loss. They develop beautiful applications for iOS backed by sophisticated algorithms and a robust, HIPAA-compliant technical stack to enable real-time monitoring during surgery. The company was incorporated in 2011 and is headquartered in Menlo Park, California.
Endotronix is a developer of hemodynamic monitoring technologies to help detect worsening heart failure earlier than ever before. The company's platform includes a cloud-based disease management data system and outpatient hemodynamic management with a breakthrough implantable wireless pulmonary artery sensor for early detection of worsening heart failure. It was founded in 2007 and is based in Lisle, Illinois.
Renovia was a developer of prescription digital therapeutics for pelvic floor disorders. Renovia ceased operations in late 2022 after its investors conducted a strategic review including considering a sale of the company. In January 2023, substantially all the assets of the company, including its intellectual property, were sold to Axena Health, Inc.
Regroup provides integrated telepsychiatry services designed to offer psychiatric care remotely through live and interactive video conferencing. They improve access to mental health care, enabling patients to overcome geographical distances, restrictions on mobility, transportation difficulties, and time and cost burdens.
Level Ex is a developer of professional medical video games designed for physicians to capture the challenges of practicing medicine. They use video game technology and cognitive neuroscience to capture the challenges of practicing medicine, allowing physicians to keep up-to-speed on rare and challenging cases, new medical devices, and drug therapies.
PatientWisdom, Inc. developed a SaaS digital health platform that transforms the experience and delivery of care by listening to the people involved, individually and at scale. The offers three powerful solutions: PatientWisdom makes it easy to understand what matters to patients ahead of clinical encounters so providers can do better without taking longer; ProviderWisdom obtains real-world insights from clinicians and staff to create more responsive ecosystems that enhance engagement, address burnout and streamline care; CommunityWisdom produces a deep view of the community to give health organizations clear lines-of-sight for developing or partnering with programs people will use. The Tech Tribune named PatientWisdom, Inc. one of the Best Tech Startups in 2018 and 2019, and PatientWisdom was named “Most-Patient Centered” and an Audience Favorite at the Health Tech StandOut! Competition during the 2018 Connected Health Conference.
Regroup provides integrated telepsychiatry services designed to offer psychiatric care remotely through live and interactive video conferencing. They improve access to mental health care, enabling patients to overcome geographical distances, restrictions on mobility, transportation difficulties, and time and cost burdens.
InsightRX is a software platform that incorporates the principles of quantitative pharmacology and machine learning to provide an individualized understanding of a patient’s response to treatment. It delivers its technology in the form of easy-to-use clinical decision support tools at the point-of-care to help guide treatment decision-making. The platform guides treatment decisions at both the individual level and the population level. InsightRX controls clinically validated pharmacokinetic models, patient physiology, pharmacogenomics, drug concentrations, and biomarkers to optimize dosing. It combines real-time patient data and machine learning to understand individual patient pharmacology and inform dose optimization. The platform also leverages disease-based pharmacodynamics models to inform treatment decision making. InsightRX was launched in 2015 by Ron Keizer, Sirj Goswami, and Ranvir Mangat. It is operated from San Francisco, California.
AVIA Health Innovation specializes in digital healthcare transformation, focusing on developing platforms and systems that enhance collaboration and knowledge sharing within the healthcare sector. The company's flagship offering, AVIA Connect, supports hospitals and health systems in identifying, selecting, and implementing innovative IT-enabled solutions that drive growth, improve operational efficiency, and enhance value. By facilitating collaboration between healthcare providers and entrepreneurs, AVIA accelerates the adoption of emerging technologies while mitigating associated risks. The company addresses critical needs in areas such as population health, clinical data insights, care model redesign, patient engagement, and operational effectiveness. Founded in 2012 and headquartered in Chicago, Illinois, AVIA serves a diverse clientele, including health systems, medical groups, health plans, and life sciences companies.
Endotronix is a developer of hemodynamic monitoring technologies to help detect worsening heart failure earlier than ever before. The company's platform includes a cloud-based disease management data system and outpatient hemodynamic management with a breakthrough implantable wireless pulmonary artery sensor for early detection of worsening heart failure. It was founded in 2007 and is based in Lisle, Illinois.
BrightWater Medical is a mid-stage medical device company uniquely positioned to significantly impact the treatment of ureteral blockages by interventional radiologists. The company was founded by Dr. Bob Smouse, Associate Professor of Radiology & Surgery, University of Illinois College of Medicine. Dr. Smouse is a leading interventional radiologist, clinician, academic and entrepreneur, with more than 20 years of experience in interventional radiology, endovascular surgery and clinical research.
Pieces is a healthcare artificial intelligence and technology company that connects health systems and the community to address clinical and social determinants of health through community networks and intelligent software and services. Our solution interprets patient information in real-time and connects health systems and community-based organizations to support healthier outcomes, both inside and outside of hospital walls. Using cloud-based artificial intelligence with clinically-based natural language processing (NLP) and physician-supervised machine learning, our tools help streamline clinician workflows and improve patient outcomes. Combined, our solutions, Pieces Predict and Pieces Connect, create a comprehensive and unique solution for connected community health.
Health Catalyst is a tech platform that organizes and links health-related data from different systems. It helps organize, normalize, and link the data from all different systems and make it searchable by all users, even the non-technical.
Pulse Therapeutics is a growing medical technology company headquartered in St. Louis, Mo. The medical developer is advancing the fight against stroke, heart disease, and other conditions with its high-level treatment solutions, which utilize the latest biomedical technology and processes. Pulse’s signature offering, the MED System, was designed to harness magnet-based technology to rapidly dissolve blood clots faster than current modalities. This faster rate of delivery of FDA-approved clot-busting medication could dramatically reduce the number of lives lost each year to stroke, heart disease, and other diseases. This pioneering medical development company was founded by leading physicists Francis “Duke” Creighton and Rogers Ritter. Dr. Creighton, who also serves as Pulse’s chief technical officer, has 20-plus years of expertise in the medical technology industry, specializing in the stroke and cardiovascular sectors. He responsible for 30 patents and is a technology reviewer for the National Cancer Institute, National Science Foundation, and National Institutes of Health. The ground-breaking medical solutions of Pulse Therapeutics continues to attract investors and garner media coverage.